[3H]N-methylscopolamine binding to muscarinic receptors in human peripheral blood lymphocytes: characterization, localization on T-lymphocyte subsets and age-dependent changes
- PMID: 2788247
- DOI: 10.1016/0028-3908(89)90157-3
[3H]N-methylscopolamine binding to muscarinic receptors in human peripheral blood lymphocytes: characterization, localization on T-lymphocyte subsets and age-dependent changes
Abstract
The properties of the binding of the muscarinic receptor ligands, [3H]quinuclidinyl benzilate ([3H]QNB) and [3H]N-methylscopolamine ([3H]NMS) in human mononuclear cells were compared. The binding of [3H]QNB showed a high, non-specific component and lack of saturability in both intact mononuclear cells and preparations of lysed mononuclear cell membranes. Conversely the specific binding of [3H]NMS had a high affinity and was saturable at concentrations greater than 30 nM in both intact and broken cells. Classical muscarinic receptor antagonists displaced specific binding of [3H]NMS binding according to the law of mass action, while displacement curves for pirenzepine and muscarinic agonists were very shallow (nH less than 1), suggesting the presence of more than one subtype of muscarinic receptor on mononuclear cell membranes. Binding studies with [3H]NMS to purified mononuclear cell subpopulations demonstrated that muscarinic binding sites were mainly localized on thymus-derived (T) lymphocytes and large granule lymphocytes. Moreover evidence is presented of an age-dependent increase of the density of muscarinic binding sites on T-lymphocytes. The results are discussed in terms of the usefulness of the binding of [3H]NMS in studying the physiological function of muscarinic receptors on human T-lymphocytes and their possible changes in patients with neurological diseases.
Similar articles
-
Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.J Pharmacol Exp Ther. 1986 Aug;238(2):554-63. J Pharmacol Exp Ther. 1986. PMID: 3755473
-
Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.J Pharmacol Exp Ther. 1989 Mar;248(3):1116-22. J Pharmacol Exp Ther. 1989. PMID: 2703964
-
Anomalous binding of [3H]N-methylscopolamine to rat brain muscarinic receptors.Eur J Pharmacol. 1985 Apr 2;110(2):263-6. doi: 10.1016/0014-2999(85)90221-3. Eur J Pharmacol. 1985. PMID: 3987816
-
Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.J Pharmacol Exp Ther. 1985 Jun;233(3):707-14. J Pharmacol Exp Ther. 1985. PMID: 3839264
-
[Analysis of muscarinic receptors on rat pancreatic acini by using 125I-quinuclidinyl benzilate and N-[3H]-methylscopolamine].Nihon Shokakibyo Gakkai Zasshi. 1991 Aug;88(8):1571-8. Nihon Shokakibyo Gakkai Zasshi. 1991. PMID: 1942611 Japanese.
Cited by
-
Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring.Environ Health Perspect. 2000 Jan;108(1):29-33. doi: 10.1289/ehp.0010829. Environ Health Perspect. 2000. PMID: 10620521 Free PMC article.
-
Neuroimmune Communication in Health and Disease.Physiol Rev. 2018 Oct 1;98(4):2287-2316. doi: 10.1152/physrev.00035.2017. Physiol Rev. 2018. PMID: 30109819 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical